← All trials
NCT05277155
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 22, 2022
- Primary completion
- Jul 22, 2022
- Completion date
- Aug 22, 2022
- First posted
- Mar 14, 2022
- Last posted
- Mar 14, 2022
- Enrollment
- 168
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of IndonesiaLead sponsor
- Government of IndonesiaCollaborator
- Government of IndonesiaStudy director
- Persahabatan General HospitalOverall official - principal investigator
- Government of IndonesiaOfficial
- Persahabatan General HospitalOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.